REQUEST A DEMO
Total
USD $0.00
Search more companies

Altadis Farmaceutica S A S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Altadis Farmaceutica S A S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Altadis Farmaceutica S A S is based in Colombia, with the head office in Bogota D.C.. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on January 27, 2015. 33 (2024) employees currently work for Altadis Farmaceutica S A S. The latest financial highlights indicate a net sales revenue increase of 146.64% in 2023. During that time, Altadis Farmaceutica S A S’s total assets grew by 159.46%. The net profit margin of Altadis Farmaceutica S A S increased by 28.95% in 2023.

Headquarters
Calle 10 65 75
Bogota D.C.; Bogota D.C; Postal Code: 0612

Contact Details: Purchase the Altadis Farmaceutica S A S report to view the information.

Basic Information
Total Employees:
Purchase the Altadis Farmaceutica S A S report to view the information.
Outstanding Shares:
Purchase the Altadis Farmaceutica S A S report to view the information.
Incorporation Date:
January 27, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Altadis Farmaceutica S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
146.64%
Total operating revenue
150.8%
Operating profit (EBIT)
564.63%
EBITDA
455.2%
Net Profit (Loss) for the Period
807.22%
Total assets
159.46%
Total equity
376.56%
Operating Profit Margin (ROS)
29.46%
Net Profit Margin
28.95%
Return on Equity (ROE)
37.51%
Debt to Equity Ratio
-0.66%
Quick Ratio
1.11%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?